Hormonal Contraceptive Market Size Worth $23.81 Billion By 2030 | CAGR: 4.3%

The global hormonal contraceptive market size is expected to reach USD 23.81 billion by 2030, according to a new study by Polaris Market Research. The report “Hormonal Contraceptive Market Share, Size, Trends, Industry Analysis Report, By Product; By Hormones (Combined Hormonal Contraceptive, Progestin-only Contraceptive); By Age; By End-Use; By Region; Segment Forecast, 2022 - 2030” gives a detailed insight into current market dynamics and provides an analysis of future market growth.

A significant increase in government activity to control population growth, awareness about family planning, and the need to prevent unplanned pregnancies showcases growth in the industry. Furthermore, the investments and availability of a diverse range of innovative preventive products and key significant players working on preventives are expected to drive industry growth.

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/hormonal-contraceptive-market/request-for-sample

In addition, other factors that are expected to propel substantial growth opportunities include rising awareness about unplanned pregnancies among teenagers. Many Asia Pacific regions such as India, China, and Japan are likely to positively impact the growth of the industry owing to updated technologies and targeted populations in these regions.

COVID-19 had a negative impact on the industry due to the lockdown and economic slowdown. It has declined supply chain and manufacturing of the preventive products, which was stabilized post-pandemic.

Hormonal contraceptives Market Report Highlights

• The demand for the combined contraceptive segment is expected to drive the market growth as demand for fewer side effects, effective and lower acne prone and other symptoms are growing over time.
• Based on product, oral pills are accounted to contribute towards higher revenue for the market as they are conveniently available and have high accuracy.
• Household segment by end-use is expected to spearhead revenue growth in the forecast period due to ease of consumption at home to avoid unplanned pregnancy.
• Asia Pacific is anticipated to grow at a CAGR of xx over the forecast period due to high unmet needs and more women moving towards their reproductive age.
• Major players operating in the industry include Ansell ltd, Abbvie Inc, Afaxys inc, Agile Therapeutics, Bayer AG, Pfizer, inc, Church & Dwight,Co,Inc, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Mylan N.V., Mayer Laboratories, Merck & co,Inc, Organon Group of companies, Pregna International Ltd, The Female Health Company

Polaris Market Research has segmented the Hormonal Contraceptive market report based on product, Hormones, Age group, end-use, and region:

Hormonal Contraceptive, Product Outlook (Revenue - USD Billion, 2021 - 2030)

• Oral contraceptive pills
• Emergency contraceptive pills
• Transdermal patches
• Injectable birth control
• Vaginal Rings

Hormonal Contraceptive, Hormones Outlook (Revenue - USD Billion, 2021 - 2030)

• Combined
• Progestin-only Contraceptive

Hormonal Contraceptive, Hormones Outlook (Revenue - USD Billion, 2021 - 2030)

• 15-24 years
• 25-34 years
• 35-44 years
• Above 44 years

Hormonal Contraceptive, End-Use Outlook (Revenue - USD Billion, 2021- 2030)

• Hospitals
• Household
• Clinics
• Gynecology centers
• Ambulatory Surgical Centers

Hormonal Contraceptive, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

• North America
• U.S
  • Canada
• Europe
• Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
• China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
• Argentina
  • Brazil
  • Mexico
• Middle East & Africa
• UAE
  • Saudi Arabia
  • Israel
  • South Africa